Kymera Therapeutics, Inc. (KYMR) NASDAQ

58.32

-2.18(-3.60%)

Updated at October 21 04:00PM

Currency In USD

Valuation

Market Cap3.02B
Enterprise Value2.99B
P/E Ratio-17.03
PEG Ratio1.43
Price/Sales Ratio93.26
Price/Book Ratio4.83
Enterprise/Revenue87.67
Enterprise/EBITDA-14.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-6.16
Operating Margin-6.98

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.32

Income Statement

Revenue47.07M
Revenue/Share0.56
Gross Profit47.07M
EBITDA-216.24M
Net Income-223.86M
Diluted EPS-2.98

Balance Sheet

Total Cash665.45M
Total Cash/Share8.27
Total Debt85.71M
Total Debt/Equity0.09
Current Ratio8.32
Book Value Per Share12.08

Price History

52-Week Change25.26
52-Week High63.96
52-Week Low19.45
Moving Average 50 Days49.22
Moving Average 200 Days40.12

Statistics

Average Volume729,782
Shares Outstanding71.5M
% Held by Institutions96.55

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A